Anthera Announces Initiation of the SOLUTION Clinical Study of Oral Sollpura(R) (liprotamase) Unit-Matched Therapy of Non-Porcine Origin in People With Cystic Fibrosis
October 02, 2015 at 12:34 PM EDT
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced the initiation of the SOLUTION (Study of Oral Liprotamase Unit-Matched ...